OM Stock Analysis: Buy, Sell, or Hold?
OM - Outset Medical, Inc. Common Stock
$5.02
0.03 (0.60%)
▲
5d:
+6.36%
30d:
-1.18%
90d:
+15.94%
BUY
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Get Alerted When OM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: OM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: OM is currently trading at $5.02, which is considered extended relative to its 30-day fair value range of $4.20 to $4.81.
Technical Outlook: Technically, OM is in a uptrend. The price is approaching resistance at $5.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.67 (+53.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OM is in a uptrend. The price is approaching resistance at $5.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.67 (+53.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.20 -
$4.81
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.6% below Wall St target ($7.67)
Trading Range Analysis
30-Day Trading Range
$4.20 -
$4.81
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.94
(18.8%)
Support & Resistance Levels
Support Level
$3.96
Resistance Level
$5.02
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.29
Wall Street Target
$7.67
(+53.6%)
Revenue Growth (YoY)
-6.3%
Profit Margin
-63.6%
Share & Embed Analysis
Last updated: August 04, 2026 11:24 AM ET
Data refreshes hourly during market hours. Next update: 12:24 PM
Data refreshes hourly during market hours. Next update: 12:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Leslie Trigg
SELL
3361 shares
2026-02-17
Marc Nash
SELL
1817 shares
2026-02-17
John L Brottem
SELL
2842 shares
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 50 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 54 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 60 HOLD |
